Metabolism

Metabolism(代谢)

研究方向

Metabolism 相关产品(3072)

  • GC35399 structure
    GC35399Artefenomel
    CAS: 1029939-86-3
    纯度: >99.00%

    An antimalarial agent

  • GC35419 structure
    GC35419Atorvastatin
    CAS: 134523-00-5
    纯度: >99.00% / >98.00% / >99.50%

    阿托伐他汀(Atorvastatin)是一种口服活性HMG-CoA还原酶抑制剂,可以有效降低血脂

  • GC35499 structure
    GC35499Bestatin trifluoroacetate
    CAS: 223763-80-2

    An aminopeptidase inhibitor

  • GC35518 structure
    GC35518Bilobetin
    CAS: 521-32-4
    纯度: >98.00%

    A biflavonoid with diverse biological activities

  • GC35536 structure
    GC35536BMS-962212
    CAS: 1430114-34-3

    BMS-962212 是直接的,可逆的,选择性 FXIa 抑制剂。 BMS-962212 具有良好的耐受性,快速起效的药效 (PD) 反应和快速消除。 BMS-962212 在活化的部分促凝血酶原激酶时间内依赖性地增加暴露,并且在 FXI 凝血活性中依赖性地降低暴露。

  • GC35543 structure
    GC35543BPN14770
    CAS: 1606974-33-7
    纯度: >99.00%

    Zatolmilast (BPN14770) is a selective allosteric inhibitor of phosphodiesterase 4D (PDE4D) with IC50 of 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3, respectively.

  • GC35565 structure
    GC35565Bucladesine calcium salt
    CAS: 938448-87-4

    Bucladesine 钙盐(Dibutyryl-cAMP 钙盐;DC2797 钙盐)是一种细胞可渗透的环 AMP (cAMP) 类似物,可通过增加细胞内 cAMP 水平选择性地激活 cAMP 依赖性蛋白激酶 (PKA)。

  • GC35603 structure
    GC35603Canagliflozin hemihydrate
    CAS: 928672-86-0
    纯度: >99.50%

    An inhibitor of SGLT2

  • GC35627 structure
    GC35627CDC25B-IN-1
    CAS: 2374831-10-2
    纯度: >98.00%

    CDC25B-IN-1 (compound 4a) 是一种有效的细胞分裂周期 25B (CDC25B) 磷酸酶抑制剂,其 Ki 值为 8.5 μM。CDC25B-IN-1 能有效抑制细胞增殖和克隆形成,导致 G2/M 期停滞。

  • GC35657 structure
    GC35657CETP-IN-3
    CAS: 939391-31-8

    CETP-IN-3 (Compound 13) 是血浆糖蛋白胆固醇酯转移蛋白 (CETP) 的小分子抑制剂,可抑制 CETP 活性并提高高密度脂蛋白胆固醇 (HDL-C) 水平。CETP-IN-3 抑制活力的IC50 值分别为0.002 μM (SPA), 0.06 μM (WPA) 。

  • GC35692 structure
    GC35692Chrysosplenetin
    CAS: 603-56-5
    纯度: >99.50%

    A flavonoid with diverse biological activities

  • GC35698 structure
    GC35698Ciprofibrate D6
    CAS: 2070015-05-1

    An internal standard for the quantification of ciprofibrate

  • GC35757 structure
    GC35757Cucurbitacin D
    CAS: 3877-86-9
    纯度: >98.00%

    A triterpenoid with diverse biological activities

  • GC35788 structure
    GC35788CYP17-IN-1
    CAS: 2093317-51-0

    CYP17-IN-1 (compound 9c) 是一种有效的,具有口服活性的 CYP17 的抑制剂,对大鼠和人 CYP17 的 IC50 值为 15.8 和 20.1 nM。

  • GC35791 structure
    GC35791cyt-PTPε Inhibitor-1
    CAS: 428478-94-8

    cyt-PTPε Inhibitor-1 是一种有效的胞质蛋白酪氨酸磷酸酶 cyt-PTPε 抑制剂,与 cyt-PTPε 的催化结构域结合,抑制 c-Src 的活化 (c-Src 去磷酸化),具有抗破骨细胞的活性。

  • GC35795 structure
    GC35795D,L-Buthionine-(S,R)-sulfoximine hydrochloride

    A γ-glutamylcysteine synthetase inhibitor

  • GC35803 structure
    GC35803Dafadine-A
    CAS: 1065506-69-5
    纯度: >98.50%

    Dafadine-A是dafadine类似物,是C. elegans DAF-9 细胞色素P450抑制剂,还能抑制哺乳动物的CYP27A1。

  • GC35809 structure
    GC35809Dapagliflozin ((2S)-1,2-propanediol, hydrate)
    CAS: 960404-48-2
    纯度: >99.50%

    Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.

  • GC35837 structure
    GC35837Deltasonamide 2 (TFA)
    CAS: 2235358-74-2
    纯度: >99.50%

    Deltasonamide 2 TFA 是一种竞争性的,高亲和力的 PDEδ 抑制剂,Kd 值约为 385 pM。

  • GC35838 structure
    GC35838Deltasonamide 2 hydrochloride
    CAS: 2448341-55-5
    纯度: >99.00%

    Deltasonamide 2 hydrochloride 是一种竞争性的,高亲和力的 PDEδ 抑制剂,Kd 值为 ~385 pM.

  • GC35876 structure
    GC35876DL-Glutamine
    CAS: 6899-04-3
    纯度: >98.00%

    DL-Glutamine (Glutamin, 2-amino-4-carbamoylbutanoic acid) is a non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes.

  • GC35962 structure
    GC35962Edoxaban tosylate
    CAS: 480449-71-6
    纯度: >99.00%

    A potent inhibitor of Factor Xa

  • GC35981 structure
    GC35981EMT inhibitor-2
    CAS: 2232228-60-1

    EMT inhibitor-2 (Compound 1) 抑制由免疫细胞释放的物质如 IL-1β 和 TGF-β 诱导的上皮-间质转化 (EMT)。EMT inhibitor-2 抑制CYP3A4 睾酮和 CYP2C9,IC50 分别为 49.72 和 5.54 μM。

  • GC36004 structure
    GC36004Ertugliflozin L-pyroglutamic acid
    CAS: 1210344-83-4
    纯度: >99.50%

    Ertugliflozin (MK-8835, PF-04971729) L-pyroglutamic acid is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2) with IC50 of 0.877 nM for h-SGLT2. Ertugliflozin has the potential for the treatment of type 2 diabetes mellitus.